What are the signs and symptoms of polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Polycythemia

Polycythemia presents with a constellation of symptoms related to hyperviscosity, thrombosis risk, and myeloproliferation, including pruritus (33%), erythromelalgia (5.3%), transient visual changes (14%), and splenomegaly (36%), with thrombotic and hemorrhagic complications representing the most life-threatening manifestations. 1

Hematologic Manifestations

Elevated blood cell counts are the hallmark laboratory findings:

  • Erythrocytosis (hemoglobin >16.5 g/dL in men or >16.0 g/dL in women) is the required diagnostic criterion 1
  • Thrombocytosis occurs in 53% of patients 1
  • Leukocytosis is present in 49% of cases and represents a PV-related feature that strengthens diagnostic suspicion 2, 1
  • Elevated hematocrit exceeding the 95th percentile for normal distribution meets criteria for suspected polycythemia vera 2

Vascular and Thrombotic Symptoms

Thrombosis is the major cause of morbidity and mortality:

  • Arterial thrombosis occurs in 16% of patients prior to or at diagnosis 1
  • Venous thrombotic events occur in 7%, potentially involving unusual sites such as splanchnic veins 1
  • Transient visual changes affect 14% of patients, reflecting microvascular occlusion 1
  • During the pre-phlebotomy era, thrombosis was the major cause of death with median life expectancy less than 2 years 3

Microcirculatory and Hyperviscosity Symptoms

Symptoms related to increased blood viscosity and microvascular occlusion:

  • Pruritus (itching) affects 33% of patients, often aquagenic (triggered by water exposure) 1, 4
  • Erythromelalgia (burning pain in extremities with redness) occurs in 5.3% 1, 4
  • Headaches and dizziness result from hyperviscosity 4
  • Fatigue is a prominent constitutional symptom 4

Physical Examination Findings

Splenomegaly is present in 36% of patients with associated abdominal discomfort 1, 4

Plethoric appearance (ruddy, reddish complexion) reflects increased red blood cell mass 5

Hemorrhagic Complications

Bleeding risk is paradoxically increased despite thrombocytosis:

  • Acquired von Willebrand disease can occur with extreme thrombocytosis (platelet count ≥1000 × 10⁹/L) 1
  • Bleeding manifestations include epistaxis, easy bruising, and gastrointestinal bleeding 6

Constitutional Symptoms

Systemic symptoms affecting quality of life:

  • Bone pain from marrow hyperplasia 4
  • Night sweats 4
  • Weight loss in some patients 4
  • Chronic fatigue despite adequate sleep, particularly when secondary to sleep apnea 7

Secondary Polycythemia Presentations

When polycythemia is secondary to hypoxemia:

  • Symptoms of underlying condition predominate (e.g., sleep apnea with obesity, chronic lung disease) 3, 7
  • Mild elevation in hemoglobin (less than 18.5 g/dL in men) is more typical of secondary causes than polycythemia vera 7
  • Patients with sleep apnea may report chronic fatigue and be unaware of sleep fragmentation 7

Critical Pitfalls to Recognize

Do not assume "adequate sleep" rules out sleep apnea as a secondary cause—patients with obstructive sleep apnea are typically unaware of their sleep fragmentation and nocturnal arousals 7

Distinguish primary from secondary polycythemia by checking serum erythropoietin levels: low EPO (<2.9 mU/mL) with specificity >90% is highly suggestive of polycythemia vera, while elevated or high-normal EPO suggests secondary causes 2, 8

Major symptoms in polycythemia rubra vera relate to arterial hypertension and arterial/venous thrombosis, and strokes may be the first manifestation 3

References

Guideline

Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Polycythemia Vera: Thinking Beyond the Hematocrit.

Journal of the advanced practitioner in oncology, 2023

Research

New Perspectives on Polycythemia Vera: From Diagnosis to Therapy.

International journal of molecular sciences, 2020

Guideline

Obstructive Sleep Apnea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polycythemia with Low Reticulocyte Count

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.